|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US4485045A
(en)
|
1981-07-06 |
1984-11-27 |
Research Corporation |
Synthetic phosphatidyl cholines useful in forming liposomes
|
|
GB8308235D0
(en)
|
1983-03-25 |
1983-05-05 |
Celltech Ltd |
Polypeptides
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4544545A
(en)
|
1983-06-20 |
1985-10-01 |
Trustees University Of Massachusetts |
Liposomes containing modified cholesterol for organ targeting
|
|
JPS6147500A
(ja)
|
1984-08-15 |
1986-03-07 |
Res Dev Corp Of Japan |
キメラモノクロ−ナル抗体及びその製造法
|
|
EP0173494A3
(en)
|
1984-08-27 |
1987-11-25 |
The Board Of Trustees Of The Leland Stanford Junior University |
Chimeric receptors by dna splicing and expression
|
|
GB8422238D0
(en)
|
1984-09-03 |
1984-10-10 |
Neuberger M S |
Chimeric proteins
|
|
US4777127A
(en)
|
1985-09-30 |
1988-10-11 |
Labsystems Oy |
Human retrovirus-related products and methods of diagnosing and treating conditions associated with said retrovirus
|
|
GB8702816D0
(en)
|
1987-02-07 |
1987-03-11 |
Al Sumidaie A M K |
Obtaining retrovirus-containing fraction
|
|
US5219740A
(en)
|
1987-02-13 |
1993-06-15 |
Fred Hutchinson Cancer Research Center |
Retroviral gene transfer into diploid fibroblasts for gene therapy
|
|
US5422120A
(en)
|
1988-05-30 |
1995-06-06 |
Depotech Corporation |
Heterovesicular liposomes
|
|
AP129A
(en)
|
1988-06-03 |
1991-04-17 |
Smithkline Biologicals S A |
Expression of retrovirus gag protein eukaryotic cells
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
DE68927933T2
(de)
|
1988-09-02 |
1997-08-14 |
Dyax Corp |
Herstellung und auswahl von rekombinantproteinen mit verschiedenen bindestellen
|
|
EP0832980B1
(en)
|
1989-01-23 |
2002-06-19 |
Chiron Corporation |
Recombinant therapies for infection and hyperproliferative disorders
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
DK0737750T3
(da)
|
1989-03-21 |
2003-09-01 |
Vical Inc |
Ekspression af exogene polynucleotidsekvenser i vertebrater
|
|
US6291158B1
(en)
|
1989-05-16 |
2001-09-18 |
Scripps Research Institute |
Method for tapping the immunological repertoire
|
|
EP1001032A3
(en)
|
1989-08-18 |
2005-02-23 |
Chiron Corporation |
Recombinant retroviruses delivering vector constructs to target cells
|
|
US5585362A
(en)
|
1989-08-22 |
1996-12-17 |
The Regents Of The University Of Michigan |
Adenovirus vectors for gene therapy
|
|
US5013556A
(en)
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
ZA911974B
(en)
|
1990-03-21 |
1994-08-22 |
Res Dev Foundation |
Heterovesicular liposomes
|
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
|
US6172197B1
(en)
|
1991-07-10 |
2001-01-09 |
Medical Research Council |
Methods for producing members of specific binding pairs
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
ES2139598T3
(es)
|
1990-07-10 |
2000-02-16 |
Medical Res Council |
Procedimientos para la produccion de miembros de parejas de union especifica.
|
|
DE69129154T2
(de)
|
1990-12-03 |
1998-08-20 |
Genentech, Inc., South San Francisco, Calif. |
Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften
|
|
DE69233697T2
(de)
|
1991-03-01 |
2008-01-24 |
Dyax Corp., Cambridge |
Verfahren zur Entwicklung von bindenden Mikroproteinen
|
|
PT100379B
(pt)
|
1991-04-10 |
1999-01-29 |
Scripps Research Inst |
Bibliotecas de receptores heterodimericos usando fagomideos
|
|
DE4122599C2
(de)
|
1991-07-08 |
1993-11-11 |
Deutsches Krebsforsch |
Phagemid zum Screenen von Antikörpern
|
|
ATE237694T1
(de)
|
1991-08-20 |
2003-05-15 |
Us Gov Health & Human Serv |
Adenovirus vermittelter gentransfer in den gastrointestinaltrakt
|
|
WO1993010218A1
(en)
|
1991-11-14 |
1993-05-27 |
The United States Government As Represented By The Secretary Of The Department Of Health And Human Services |
Vectors including foreign genes and negative selective markers
|
|
GB9125623D0
(en)
|
1991-12-02 |
1992-01-29 |
Dynal As |
Cell modification
|
|
PT1024191E
(pt)
|
1991-12-02 |
2008-12-22 |
Medical Res Council |
Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos
|
|
FR2688514A1
(fr)
|
1992-03-16 |
1993-09-17 |
Centre Nat Rech Scient |
Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant.
|
|
EP0650370A4
(en)
|
1992-06-08 |
1995-11-22 |
Univ California |
METHODS AND COMPOSITIONS TARGETED ON SPECIFIC TISSUES.
|
|
EP0644946A4
(en)
|
1992-06-10 |
1997-03-12 |
Us Health |
VECTOR PARTICLES RESISTANT TO INACTIVATION BY HUMAN SERUM.
|
|
GB2269175A
(en)
|
1992-07-31 |
1994-02-02 |
Imperial College |
Retroviral vectors
|
|
EP0673431A1
(en)
|
1992-12-03 |
1995-09-27 |
Genzyme Corporation |
Gene therapy for cystic fibrosis
|
|
US5981568A
(en)
|
1993-01-28 |
1999-11-09 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
|
US5994618A
(en)
|
1997-02-05 |
1999-11-30 |
Johns Hopkins University School Of Medicine |
Growth differentiation factor-8 transgenic mice
|
|
CA2157577C
(en)
|
1993-03-19 |
2009-11-17 |
Se-Jin Lee |
Growth differentiation factor-8
|
|
US7566768B1
(en)
*
|
1995-10-26 |
2009-07-28 |
The Johns Hopkins University School Of Medicine |
Promyostatin peptides and methods of using same
|
|
US7393682B1
(en)
|
1993-03-19 |
2008-07-01 |
The Johns Hopkins University School Of Medicine |
Polynucleotides encoding promyostatin polypeptides
|
|
AU6818094A
(en)
|
1993-04-22 |
1994-11-08 |
Depotech Corporation |
Cyclodextrin liposomes encapsulating pharmacologic compounds and methods for their use
|
|
EP0705344B8
(en)
|
1993-06-24 |
2006-05-10 |
Advec Inc. |
Adenovirus vectors for gene therapy
|
|
WO1995007994A2
(en)
|
1993-09-15 |
1995-03-23 |
Viagene, Inc. |
Recombinant alphavirus vectors
|
|
US6015686A
(en)
|
1993-09-15 |
2000-01-18 |
Chiron Viagene, Inc. |
Eukaryotic layered vector initiation systems
|
|
DE69435223D1
(de)
|
1993-10-25 |
2009-09-03 |
Canji Inc |
Rekombinanter Adenoviren-Vektor und Verfahren zur Verwendung
|
|
HUT75162A
(en)
|
1993-11-16 |
1997-04-28 |
Depotech Corp |
Vesicles with controlled release of actives
|
|
DE69535669T2
(de)
|
1994-05-09 |
2008-12-04 |
Oxford Biomedica (Uk) Ltd. |
Retrovirale vektoren mit verminderter rekombinationsrate
|
|
US20030167492A1
(en)
|
1994-07-08 |
2003-09-04 |
Johns Hopkins University School Of Medicine |
Transgenic non-human animals expressing a gdf-11 dominant negative polypeptide, and methods of making and using same
|
|
DE69534468T2
(de)
|
1994-07-08 |
2006-07-13 |
The Johns Hopkins University School Of Medicine |
Wachstums-differenzierungsfaktor-11
|
|
WO1996017072A2
(en)
|
1994-11-30 |
1996-06-06 |
Chiron Viagene, Inc. |
Recombinant alphavirus vectors
|
|
DE69739286D1
(de)
|
1996-05-06 |
2009-04-16 |
Oxford Biomedica Ltd |
Rekombinationsunfähige retrovirale vektoren
|
|
US6656475B1
(en)
|
1997-08-01 |
2003-12-02 |
The Johns Hopkins University School Of Medicine |
Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same
|
|
US6891082B2
(en)
|
1997-08-01 |
2005-05-10 |
The Johns Hopkins University School Of Medicine |
Transgenic non-human animals expressing a truncated activintype II receptor
|
|
GB9722131D0
(en)
|
1997-10-20 |
1997-12-17 |
Medical Res Council |
Method
|
|
WO2000053211A2
(en)
|
1999-03-09 |
2000-09-14 |
University Of Southern California |
Method of promoting myocyte proliferation and myocardial tissue repair
|
|
PL357017A1
(en)
|
2000-01-28 |
2004-07-12 |
Novo Nordisk A/S |
Alkynylsubstituted propionic acid derivatives and their use against diabetes and obesity
|
|
AU2001268427B2
(en)
|
2000-06-16 |
2007-03-29 |
Glaxosmithkline Intellectual Property Limited |
Antibodies that immunospecifically bind to blys
|
|
AU2011244851A1
(en)
|
2000-07-27 |
2011-11-24 |
The John Hopkins University School Of Medicine |
Promyostatin peptides and methods of using same
|
|
EP1355919B1
(en)
|
2000-12-12 |
2010-11-24 |
MedImmune, LLC |
Molecules with extended half-lives, compositions and uses thereof
|
|
US7320789B2
(en)
*
|
2001-09-26 |
2008-01-22 |
Wyeth |
Antibody inhibitors of GDF-8 and uses thereof
|
|
ATE364632T1
(de)
|
2001-10-05 |
2007-07-15 |
Affimed Therapeutics Ag |
Antikörper menschlichen ursprungs zur hemmung der thrombozytenaggregation
|
|
US8455627B2
(en)
|
2001-10-05 |
2013-06-04 |
Affimed Therapeutics, Ag |
Human antibody specific for activated state of platelet integrin receptor GPIIb/IIIa
|
|
US20040044063A1
(en)
|
2002-05-31 |
2004-03-04 |
Brent Stockwell |
SMA therapy and cell based assay for identifying therapies
|
|
US20040131614A1
(en)
|
2002-07-19 |
2004-07-08 |
Abbott Biotechnology Ltd. |
Treatment of pulmonary disorders using TNFalpha inhibitor
|
|
AU2003267246A1
(en)
|
2002-09-16 |
2004-04-30 |
The Johns Hopkins University |
Metalloprotease activation of myostatin, and methods of modulating myostatin activity
|
|
US7261893B2
(en)
*
|
2002-10-22 |
2007-08-28 |
Wyeth |
Neutralizing antibodies against GDF-8 and uses therefor
|
|
JP4754219B2
(ja)
|
2002-12-02 |
2011-08-24 |
アムジエン・フレモント・インコーポレイテツド |
腫瘍壊死因子を対象とする抗体、およびそれらの使用
|
|
AU2003301195B2
(en)
|
2002-12-20 |
2010-01-07 |
Amgen Inc. |
Binding agents which inhibit myostatin
|
|
WO2005066204A2
(en)
*
|
2003-12-31 |
2005-07-21 |
Schering-Plough Ltd. |
Neutralizing epitope-based growth enhancing vaccine
|
|
CA2558478A1
(en)
|
2004-03-02 |
2005-09-15 |
Acceleron Pharma Inc. |
Alk7 and myostatin inhibitors and uses thereof
|
|
US20070178095A1
(en)
|
2004-03-23 |
2007-08-02 |
Eli Lilly And Company |
Anti-myostatin antibodies
|
|
EP1740946B1
(en)
|
2004-04-20 |
2013-11-06 |
Genmab A/S |
Human monoclonal antibodies against cd20
|
|
EP1755648A2
(en)
|
2004-05-27 |
2007-02-28 |
Acceleron Pharma Inc. |
Cerberus/coco derivatives and uses thereof
|
|
CA2575791A1
(en)
|
2004-08-03 |
2006-02-16 |
Dyax Corp. |
Hk1-binding proteins
|
|
EP2361933A3
(en)
|
2005-01-26 |
2012-05-02 |
Amgen Fremont Inc. |
Antibodies against interleukin-1 beta
|
|
US20060216279A1
(en)
|
2005-03-22 |
2006-09-28 |
Glass David J |
Myostatin inhibiting fusion polypeptides and therapeutic methods thereof
|
|
TW200724548A
(en)
|
2005-04-25 |
2007-07-01 |
Pfizer |
Antibodies to myostatin
|
|
US7888486B2
(en)
*
|
2005-08-19 |
2011-02-15 |
Wyeth Llc |
Antagonist antibodies against GDF-8
|
|
KR101135220B1
(ko)
|
2005-10-06 |
2012-04-24 |
일라이 릴리 앤드 캄파니 |
항-마이오스타틴 항체
|
|
UA92504C2
(en)
|
2005-10-12 |
2010-11-10 |
Эли Лилли Энд Компани |
Anti-myostatin monoclonal antibody
|
|
US8067562B2
(en)
*
|
2005-11-01 |
2011-11-29 |
Amgen Inc. |
Isolated nucleic acid molecule comprising the amino acid sequence of SEQ ID NO:1
|
|
WO2007061995A2
(en)
|
2005-11-21 |
2007-05-31 |
Novartis Ag |
Biomarkers for statin-induced myopathy or rhabdomyolysis
|
|
KR20070105685A
(ko)
|
2006-04-27 |
2007-10-31 |
영남대학교 산학협력단 |
메트포르민을 포함하는 비만치료용 조성물
|
|
US8097596B2
(en)
|
2006-06-30 |
2012-01-17 |
Lakewood-Amedex, Inc. |
Compositions and methods for the treatment of muscle wasting
|
|
BRPI0715072A2
(pt)
|
2006-08-03 |
2013-06-25 |
Orico Ltd |
antagonistas de miostatina
|
|
WO2008030367A2
(en)
|
2006-09-01 |
2008-03-13 |
The General Hospital Corporation |
Selective myostatin inhibitors
|
|
HRP20130320T1
(en)
|
2006-09-05 |
2013-05-31 |
Eli Lilly And Company |
Anti-myostatin antibodies
|
|
WO2008067480A2
(en)
|
2006-11-29 |
2008-06-05 |
Nationwide Children's Hospital |
Myostatin inhibition for enhancing muscle and/or improving muscle function
|
|
KR101531722B1
(ko)
|
2007-03-30 |
2015-06-25 |
메르크 파텐트 게엠베하 |
음성 광학 분산도를 갖는 복굴절층
|
|
AU2008260445A1
(en)
|
2007-06-01 |
2008-12-11 |
Biogen Idec Ma Inc. |
Cripto binding molecules
|
|
TW200918553A
(en)
|
2007-09-18 |
2009-05-01 |
Amgen Inc |
Human GM-CSF antigen binding proteins
|
|
PE20091163A1
(es)
|
2007-11-01 |
2009-08-09 |
Wyeth Corp |
Anticuerpos para gdf8
|
|
TW201029662A
(en)
|
2008-12-19 |
2010-08-16 |
Glaxo Group Ltd |
Novel antigen binding proteins
|
|
US8952130B2
(en)
|
2009-02-24 |
2015-02-10 |
The Salk Institute For Biological Studies |
Designer ligands of TGF-β superfamily
|
|
JP2012520887A
(ja)
|
2009-03-18 |
2012-09-10 |
シェーリング コーポレイション |
ジアシルグリセロールアシルトランスフェラーゼの阻害剤としての二環式化合物
|
|
ES2655877T3
(es)
|
2009-04-27 |
2018-02-22 |
Novartis Ag |
Composiciones y métodos para aumentar el crecimiento muscular
|
|
MX355042B
(es)
|
2009-06-08 |
2018-04-02 |
Acceleon Pharma Inc |
Metodos para aumentar adipositos termogenicos.
|
|
US8945511B2
(en)
|
2009-06-25 |
2015-02-03 |
Paul Weinberger |
Sensitive methods for detecting the presence of cancer associated with the over-expression of galectin-3 using biomarkers derived from galectin-3
|
|
NZ599604A
(en)
|
2009-10-01 |
2014-07-25 |
Myostin Therapeutics Pty Ltd |
Synthetic myostatin peptide antagonists
|
|
EP3904391B1
(en)
|
2010-03-10 |
2024-07-10 |
Genmab A/S |
Monoclonal antibodies against c-met
|
|
TWI667346B
(zh)
|
2010-03-30 |
2019-08-01 |
中外製藥股份有限公司 |
促進抗原消失之具有經修飾的FcRn親和力之抗體
|
|
JO3340B1
(ar)
|
2010-05-26 |
2019-03-13 |
Regeneron Pharma |
مضادات حيوية لـعامل تمايز النمو 8 البشري
|
|
AR081556A1
(es)
*
|
2010-06-03 |
2012-10-03 |
Glaxo Group Ltd |
Proteinas de union al antigeno humanizadas
|
|
PH12013500315A1
(en)
*
|
2010-08-16 |
2013-04-29 |
Amgen Inc |
Antibodies that bind myostatin, compositions and methods
|
|
US8551892B2
(en)
|
2011-07-27 |
2013-10-08 |
Asm Japan K.K. |
Method for reducing dielectric constant of film using direct plasma of hydrogen
|
|
WO2013071056A2
(en)
|
2011-11-11 |
2013-05-16 |
Duke University |
Combination drug therapy for the treatment of solid tumors
|
|
SMT201800092T1
(it)
|
2011-11-14 |
2018-03-08 |
Regeneron Pharma |
Composizioni e metodi per aumentare la massa muscolare e la forza muscolare antagonizzando specificamente gdf8 e/o activina a
|
|
US20130178454A1
(en)
|
2011-11-17 |
2013-07-11 |
Shalender Bhasin |
Combination of testosterone and ornithine decarboxylase (odc) inhibitors
|
|
WO2013148284A1
(en)
|
2012-03-29 |
2013-10-03 |
Genentech, Inc. |
Antibodies that bind to a pcsk9 cleavage site and methods of use
|
|
WO2013165972A2
(en)
|
2012-04-30 |
2013-11-07 |
Cell Signaling Technology, Inc. |
Anti-hepatitis b virus antibodies and use thereof
|
|
MY177331A
(en)
|
2012-06-15 |
2020-09-12 |
Pfizer |
Improved antagonist antibodies against gdf-8 and uses therefor
|
|
US20150284455A1
(en)
|
2012-11-06 |
2015-10-08 |
Scholar Rock, Inc. |
Compositions and methods for modulating cell signaling
|
|
BR112015027336A2
(pt)
|
2013-05-01 |
2017-09-26 |
Genzyme Corp |
composições e processos para tratamento de atrofia muscular espinhal
|
|
HRP20201914T1
(hr)
*
|
2013-05-06 |
2021-01-22 |
Scholar Rock, Inc. |
Sastavi i postupci za modulaciju faktora rasta
|
|
EP2853898B1
(en)
|
2013-09-27 |
2017-01-04 |
Medizinische Hochschule Hannover |
Analysis of myostatin in serum
|
|
US10004814B2
(en)
|
2013-11-11 |
2018-06-26 |
Sirna Therapeutics, Inc. |
Systemic delivery of myostatin short interfering nucleic acids (siNA) conjugated to a lipophilic moiety
|
|
WO2015195094A1
(en)
|
2014-06-17 |
2015-12-23 |
Ember Therapeutics, Inc. |
Anti-activin and nati-myostatin antibodies and methods of using the same
|
|
WO2016073879A2
(en)
|
2014-11-06 |
2016-05-12 |
Scholar Rock, Inc. |
Transforming growth factor-related antibodies and uses thereof
|
|
WO2016073853A1
(en)
|
2014-11-06 |
2016-05-12 |
Scholar Rock, Inc. |
Anti-pro/latent-myostatin antibodies and uses thereof
|
|
MX2017005774A
(es)
*
|
2014-12-19 |
2017-07-28 |
Chugai Pharmaceutical Co Ltd |
Anticuerpos antimiostatina, polipeptidos que contienen regiones fc variantes, y metodos de uso.
|
|
WO2016168613A1
(en)
|
2015-04-15 |
2016-10-20 |
Regeneron Pharmaceuticals, Inc. |
Methods of increasing strength and functionality with gdf8 inhibitors
|
|
EA038146B1
(ru)
|
2015-09-15 |
2021-07-13 |
Сколар Рок, Инк. |
Антитела к про-/латентному миостатину и их применения
|
|
EA201891420A1
(ru)
|
2015-12-18 |
2019-02-28 |
Чугаи Сейяку Кабусики Кайся |
Антитела к миостатину, полипептиды, содержащие варианты fc-областей, и способы их применения
|
|
CN115814077A
(zh)
|
2016-01-08 |
2023-03-21 |
供石公司 |
抗-原肌生长抑制素/潜伏肌生长抑制素抗体及其使用方法
|
|
PL4218804T3
(pl)
|
2016-06-13 |
2026-05-25 |
Scholar Rock, Inc. |
Stosowanie inhibitorów miostatyny i terapii skojarzonych
|
|
JOP20190152A1
(ar)
|
2016-12-21 |
2019-06-20 |
Novartis Ag |
مضادات الميوستاتين، الآكتيفين أو مستقبلات الآكتيفين للاستخدام في علاج السمنة والحالات ذات الصلة
|
|
WO2018129395A1
(en)
|
2017-01-06 |
2018-07-12 |
Scholar Rock, Inc. |
Methods for treating metabolic diseases by inhibiting myostatin activation
|
|
HRP20230308T1
(hr)
|
2017-01-06 |
2023-05-12 |
Scholar Rock, Inc. |
Liječenje metaboličkih bolesti putem inhibiranja aktivacije miostatina
|
|
US20210087250A1
(en)
|
2018-04-06 |
2021-03-25 |
Cyprumed Gmbh |
Pharmaceutical compositions for the transmucosal delivery of therapeutic peptides and proteins
|
|
SG11202108099WA
(en)
|
2019-01-30 |
2021-08-30 |
Scholar Rock Inc |
LTBP COMPLEX-SPECIFIC INHIBITORS OF TGFβ AND USES THEREOF
|
|
EP4232151B1
(en)
|
2020-10-26 |
2025-10-22 |
Scholar Rock, Inc. |
Use of anti-pro/latent myostatin antibody for treating spinal muscular atrophy
|
|
CN117545842A
(zh)
|
2021-01-29 |
2024-02-09 |
拜奥卡德联合股份公司 |
SMN1和miR-23a在治疗脊髓性肌萎缩中的协同效应
|
|
DK4358995T3
(da)
|
2021-06-23 |
2026-02-02 |
Scholar Rock Inc |
Myostatin-vej-hæmmer i kombination med en glp-1-vej-aktivator til brug ved behandling af metaboliske forstyrrelser
|
|
LT4518970T
(lt)
|
2022-05-04 |
2026-04-27 |
Scholar Rock, Inc. |
Miostatino inhibitoriaus panaudojimas spinalinės raumenų atrofijos gydymui
|
|
JP2025532651A
(ja)
|
2022-09-21 |
2025-10-01 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
肥満、糖尿病および肝機能障害を処置する方法
|
|
CN120677175A
(zh)
|
2022-12-22 |
2025-09-19 |
供石公司 |
肌生成抑制蛋白活化的选择性和强效抑制剂
|